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Abstract
In Denmark, several laboratories use PCR as a routine diagnostic method for Legionnaires’ disease, and almost all PCR-positive samples
are investigated by culture. From 1993 to 2010, isolates of Legionella species other than Legionella pneumophila were obtained from
respiratory samples from 33 patients, and from 1997 to 2010, 42 isolates of Legionella non-pneumophila species were obtained and saved
from water samples from 39 different sites in Denmark. Macrophage infectivity potentiator gene (mip) sequencing was used as a refer-
ence method to identify the Legionella non-pneumophila species. Only one of the 75 isolates did not meet the acceptance criterion of a
similarity of ‡98% to sequences in the database. The species distribution between clinical and environmental isolates varied. For the for-
mer, four species were detected, with Legionella bozemanae and Legionella micdadei predominating (both 44%). For the latter, eight spe-
cies were detected, with Legionella anisa predominating (52%). The distribution among the Danish clinical isolates was different from the
general distribution both in Europe and outside Europe, where L. bozemanae and Legionella longbeachae are the most commonly found
clinical Legionella non-pneumophila species. The 75 isolates were also investigated by matrix-assisted laser desorption ionization time-of-
ﬂight mass spectrometry (MALDI-TOF MS): 64 were correctly identiﬁed, with a score of ‡2.0; eight had a score of <2.0, but only two
of these were wrongly identiﬁed; and three gave no results with MALDI-TOF MS. Both mip sequencing and MALDI-TOF MS are robust
methods for Legionella species identiﬁcation.
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Introduction
More than 50 species of Legionella have been identiﬁed, and
at least 18 of them have been associated with human dis-
ease [1,2]. It is generally supposed that >90% of cases of
Legionnaires’ disease in Europe and the USA are caused by
Legionella pneumophila, but the real number of cases caused
by other Legionella species is not well established, as the
infections are difﬁcult to diagnose. In Australia and New
Zealand, however, Legionella longbeachae appears to be
responsible for up to half of the cases of Legionnaires’ dis-
ease [3]. These cases are caused by transmission of the bac-
teria from compost, and, in recent years, this has also been
demonstrated in Europe [4].
Infections caused by Legionella species other than L. pneu-
mophila are probably often not diagnosed, owing to limita-
tions of the current diagnostic methods, which are biased
towards the detection of L. pneumophila. The most com-
monly used diagnostic method detects urinary antigen, but
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all available tests are sensitive only to L. pneumophila (espe-
cially serogroup 1). In Denmark, several laboratories use
PCR as a routine diagnostic method for Legionnaires’ dis-
ease. In most instances, primers speciﬁc for L. pneumophila
and primers speciﬁc for Legionella species are used. Almost
all PCR-positive samples are investigated by culture.
The classic phenotypic methods are difﬁcult and time-con-
suming, and several genotyping methods have been
described, e.g. total genomic DNA analysis, analysis of spe-
ciﬁc genes, and analysis of internal genes. Of these methods,
PCR ampliﬁcation and sequencing of the macrophage infectiv-
ity potentiator gene (mip) seems to be a reliable method [5],
and has become a standard method; the database, established
by members of the European Working Group for Legionella
Infections (EWGLI), is freely accessible and contains data
from all valid described species [6].
Recently, a rapid and relatively inexpensive method has
emerged, matrix-assisted laser desorption ionization time-of-
ﬂight mass spectrometry (MALDI-TOF MS). Most bacterial
species have speciﬁc protein proﬁles, which are used as dis-
crimination factors in MALDI-TOF MS [7,8].
In this study, we used mip sequencing to identify the spe-
ciﬁc species of the Legionella non-pneumophila isolates. The
distribution of species isolated from clinical samples was
compared with the distribution of Legionella non-pneumophila
species found in environmental water samples. We also per-
formed MALDI-TOF MS on all isolates to compare and vali-
date the two identiﬁcation methods for Legionella species in
a routine setting.
Materials and Methods
From 1993 to 2010, we obtained 33 isolates of Legionella
non-pneumophila species from respiratory samples from 33
patients. The strains were either isolated by culture at the
Statens Serum Institut (SSI) or submitted to the SSI from
local laboratories for species identiﬁcation. All clinical Legio-
nella isolates in Denmark are submitted to the SSI on a vol-
untary basis for identiﬁcation and serogroup determination.
In the period from 1997 to 2010, 42 isolates of Legionella
non-pneumophila species were obtained and saved from
water samples from 39 different sites in Denmark (three
locations had two species). Most of the strains were isolated
at the SSI from samples either collected as part of investiga-
tions of possible sources of Legionnaires’ disease (single
cases or clusters) or collected as routine samples. In several
other cases, the Legionella non-pneumophila isolates were not
saved for further analysis, as they were not considered to be
relevant for the investigation.
Culture
All clinical specimens were obtained from the respiratory
tract, and Legionella species were isolated with standard
methods incorporating culture on MWY-O or/and BCYE
agar. Water samples were cultured with standard methods
on GVPC or/and MWY-O plates. All isolates were subcul-
tured on BCYE plates.
mip sequencing
The isolates were identiﬁed to the species level by mip
sequencing [5]. The resulting DNA sequences were entered
into the EWGLI database (http://www.hpa-bioinfotools.org.
uk/mip_ID.html), which is hosted by the Health Protection
Agency (London) as a ﬂat text ﬁle in order to allow identiﬁ-
cation with the similarity tool. The species showing the high-
est similarity (%) according to the similarity tool was
accepted as the identiﬁed species. For a conﬁdent identiﬁca-
tion, the mip sequence submitted had to show ‡98% similar-
ity to a sequence in the database [6].
MALDI-TOF MS
All clinical isolates were subjected to MALDI-TOF MS,
according to the instructions of the manufacturer. Measure-
ments were performed with a Microﬂex mass spectrometer
(Bruker Daltonics, Bremen, Germany), using Flexcontrol ver-
sion 3.0, and spectra were imported and analysed with
MALDI Biotyper (version 2.0; Bruker Daltonics).
The MALDI-TOF MS software FlexControl was calibrated
with the Bruker Bacterial Test Standard. The Bacterial Test
Standard is a combination of six Escherichia coli peaks and RNase
A and myoglobin. MALDI-TOF MS proﬁle spectra were gener-
ated with Legionella isolates and evaluated against the MALDI
Biotyper database to ﬁnally obtain species identiﬁcation. In our
version of the database, a total of 29 Legionella species are pres-
ent, meaning that it is approximately 20 species short of being a
complete database (see Supporting Information). Results were
expressed as log-score values ranging from 0 to 3, where values
of >1.7 are generally used for reliable genus identiﬁcation and
values of >2.0 for reliable species identiﬁcation [9].
16S rRNA sequencing
Four isolates with inconsistent results by one of the two
identiﬁcation methods were submitted to 16S rRNA
sequencing, with 07F and 1509R primers for ampliﬁcation
and 07F (5¢-AAGAGTTTGATCATGGCTCA-3¢), 784FX
(5¢-AAGAGTTTGATCATGGCTCA-3¢), 804RX (5¢-GACTA
CCNGGGTATCTAATCC-3¢) and 1509R (5¢-GTTACCTTG
TTACGACTTCAC-3¢) for sequencing. For identiﬁcation, the
sequences were submitted to the BLAST tool from the
NCBI (http://blast.ncbi.nlm.nih.gov/).
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Results and Discussion
The species identiﬁed by mip sequencing and the distribution
of each of them are shown in Fig. 1. Four different species
were identiﬁed from patients, and eight from environmental
samples. The distribution of Legionella non-pneumophila spe-
cies in the environmental samples was different from that in
the clinical samples. Even though Legionella anisa (n = 22,
52.4%) is the most commonly detected environmental
(water) Legionella non-pneumophila species, it does not cause
many infections in humans (no Danish cases). In contrast,
Legionella bozemanae (often referred to as Legionella bozema-
nii in the literature), the phylogenetically closest species, is
not often found in the environment, but, together with Legio-
nella micdadei, it is the most common cause of culture-veri-
ﬁed Legionella non-pneumophila infections in Denmark (for
both, n = 15, 44%). The discrepancy in distribution might be
the result of differing levels of human pathogenicity between
Legionella species. Although the pathogenicity of L. anisa must
be considered to be low, a recent French study has indicated
that detection of L. anisa in environmental water samples
(primarily hospital water samples) might mask contamination
with L. pneumophila, resulting in a risk of infection with
L. pneumophila [10].
European data from 2007–2008 showed that only 8.8%
(1042) of all cases were diagnosed by culture, 1.8% (19/
1042) of which were identiﬁed as Legionella non-pneumophila
species. The predominant species were L. longbeachae
(n = 9) and L. bozemanae (n = 4) [11]. In Denmark, L. longbe-
achae is not a commonly detected species, among either
patient isolates or environmental (water) isolates. However,
the presence of L. longbeachae in compost that is commer-
cially available in Denmark has never been investigated.
An international survey from 2001 showed that Legionella
non-pneumophila species were rare in clinical samples; L. long-
beachae and L. bozemanae were also the predominant species
in this study, and accounted for 6.3%, the remaining species
accounting for 2.2% of a total of 8.8% [3]. The international
survey included results from Australia, New Zealand, the
USA, and Europe. The percentages of Legionella species in
clinical samples were somewhat higher than the European
numbers, which might indicate that infections with species
other than L. pneumophila are more common outside Europe
(e.g. Australia, with many L. longbeachae cases).
From 1993 to 2010, c. 1800 cases of laboratory-diagnosed
Legionnaires’ disease were registered in Denmark. Legionella
species were isolated from 732 of the cases (41%). Of the
732 cases, 33 were caused by Legionella non-pneumophila spe-
cies (4.5%). In Denmark, several laboratories routinely use
PCR, which can detect ‘all’ Legionella species, and in the time
period from 1996 (when PCR was introduced as a routine
test at the SSI), c. 70 patients were reported with positive
PCR results for Legionella non-pneumophila species (on aver-
age, seven annually), corresponding to c. 7% of all cases.
However, not all of the 70 cases were considered to be
Legionnaires’ disease cases (not fulﬁlling the clinical crite-
rion). In general, only the culture-conﬁrmed Legionella
non-pneumophila cases were considered and registered as
Legionnaires’ disease cases. We are aware that only Legio-
nella non-pneumophila species that are able to grow on the
selected media in the given routine growth conditions are
presented in this study. It is well known that not all species
grow equally well on artiﬁcial media, and co-culture with
amoebae is necessary for some, especially those from envi-
ronmental samples [12].
In our study, mip sequencing was used as reference identi-
ﬁcation method. Of the 75 isolates examined, only three did
not meet the acceptance criterion of 98% similarity: one iso-
late identiﬁed as L. bozemanae (R5296) (97.31%), one identi-
ﬁed as L. micdadeii (R294) (97.95%), and one identiﬁed as
Legionella moravica (R5868) (94.56%). For all three isolates,
mip sequencing was repeated, and they were also subjected
to 16S rRNA sequencing. When mip sequencing was
repeated, both the L. bozemanae and the L. micdadei isolates
met the acceptance criterion (Table 1), but the L. micdadei
isolate had still an unexpectedly low value of 98.31%; how-
ever, the isolate was conﬁrmed as L. micdadei by 16S rRNA
sequencing. The L. bozemanae isolate was also conﬁrmed as
L. bozemanae by 16S rRNA sequencing. On re-examination
of the ‘L. moravica’ isolate, a low mip value was found again
(92.20%), and when the 16S rRNA sequence was submitted
to BLAST, the best match was found to be with an uncul-
tured environmental bacterium and the second best match
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with Legionella worsliensis, indicating that this isolate might
represent a new Legionella species that should be investigated
further. Both the mip sequence and the 16S rRNA sequence
have been submitted to GenBank (accession nos. JN700525
and JN700525, respectively).
MALDI-TOF MS has not yet been widely used as an iden-
tiﬁcation method for Legionella species. Fujinami et al. [13]
found that MALDI-TOF MS shows equally high discrimina-
tion of Legionella species as pulsed-ﬁeld gel electrophoresis.
Gaia et al. [14] found that, with the creation of a database
of Legionella isolates with several spectra for each species
(SuperSpectra), MALDI-TOF MS could be a reliable method
for the identiﬁcation of Legionella species. Moliner et al. [8]
evaluated the use of MALDI-TOF MS for the identiﬁcation
of 21 Legionella species, and found that the sensitivity was
89.9% at the species level as compared with mip sequencing.
In our study, we found that three of the 33 patient isolates
had a score of <2.0, providing a sensitivity of 90.6%. The
three isolates were, however, correctly identiﬁed according
to the mip sequencing results, but with a score just below
2.0 (Legionella dumoﬁi, 1.8; L. bozemanae, 1.9; L. micdadeii,
1.9). Thirty-four of the 42 environmental isolates were cor-
rectly identiﬁed, with a score of ‡2.0 (79%). Of the eight
environmental isolates that had a score of <2.0, three were
identiﬁed by mip sequencing as Legionella londiniensis
(Table 1). In our version of the Bruker database, updated in
2010 (Supporting Information), no reference spectra for
L. londiniensis were present, which explains the missing
match. Of the remaining ﬁve isolates, three were found to
be Legionella rubilucens (R4650), Legionella oakridgen-
sis (R3206) and ‘L. moravica’ (R5868) by mip sequencing; the
database only had one reference spectrum for each of
these. The L. rubrilucens isolate was correctly identiﬁed, with
a score of 1.8. The L. oakridgensis isolate was not identiﬁed
as Legionella by MALDI-TOF MS, and the ‘L. moravica’ isolate
was, as previously mentioned, probably not L. moravica but
a new Legionella species. The fourth isolate, called Legionella
‘91-004’ (R4135), was wrongly found by MALDI-TOF MS to
TABLE 1. Macrophage infectivity potentiator gene (mip)
sequencing similarity percentage and matrix-assisted laser
desorption ionization time-of-ﬂight mass spectrometry
(MALDI-TOF MS) score
Isolate no.
Presumptive
species
mip
percentage
MALDI-TOF
MS score
Patient isolates
R1639 L. bozemanae 100.00 2.0
R2805 L. bozemanae 100.00 2.1
R2806 L. bozemanae 100.00 2.2
R4873 L. bozemanae 100.00 2.0
R6058 L. bozemanae 100.00 1.9
470 L. bozemanae 100.00 2.2
R4611 L. bozemanae 99.81 2.0
R5295 L. bozemanae 99.81 2.0
R2285 L. bozemanae 99.78 2.1
R353 L. bozemanae 99.63 2.0
R3520 L. bozemanae 99.62 2.0
R5294 L. bozemanae 99.59 2.0
R1731 L. bozemanae 99.56 2.0
R569 L. bozemanae 99.46 2.3
R5296 L. bozemanae 97.31/99.60 2.1
R2702 L. dumofﬁi 100.00 1.8
R113 L. longbeachae 100.00 2.0
R267 L. longbeachae 100.00 2.2
R2354 L. longbeachae 99.79 2.2
R1349 L. micdadei 100.00 2.3
R1508 L. micdadei 100.00 2.0
R1581 L. micdadei 100.00 2.2
R1637 L. micdadei 100.00 2.2
R1641 L. micdadei 100.00 2.0
R4181 L. micdadei 100.00 2.0
R4621 L. micdadei 100.00 2.0
R4152 L. micdadei 99.82 2.0
R1644 L. micdadei 99.81 2.2
R4129 L. micdadei 99.80 2.3
R4155 L. micdadei 99.80 2.2
R1510 L. micdadei 99.76 1.8
R3594 L. micdadei 99.66 2.2
R3265 L. micdadei 98.63 2.0
R294 L. micdadei 97.95/98.31 2.1
Environmental isolates
R4135 Legionella 91-004 99.28 L. dumoﬁi 1.7
R1064 L. anisa 100.00 2.2
R1710 L. anisa 100.00 2.3
R1754 L. anisa 100.00 2.4
R3712 L. anisa 100.00 2.4
R3720 L. anisa 100.00 2.4
R4268 L. anisa 100.00 2.4
R4587 L. anisa 100.00 1.8
R4791 L. anisa 100.00 2.3
R4853 L. anisa 100.00 2.2
R4890 L. anisa 100.00 2.1
R5196 L. anisa 100.00 2.4
R5519 L. anisa 100.00 2.2
R5548 L. anisa 100.00 2.2
R5662 L. anisa 100.00 2.2
R5881 L. anisa 100.00 2.2
R5980 L. anisa 100.00 2.2
R6057 L. anisa 100.00 2.2
R6098 L. anisa 100.00 2.3
R6101 L. anisa 100.00 2.1
R5800 L. anisa 99.81 2.2
R3872 L. anisa 99.80 2.4
R4433 L. anisa 99.80 2.4
R1747 L. bozemanae 100.00 2.0
R2419 L. bozemanae 100.00 2.2
R4737 L. bozemanae 100.00 2.1
R3604 L. bozemanae 98.67 2.0
R550 L. londiniensis 100.00 NI
R4738 L. londiniensis 100.00 NI
R4674 L. londiniensis 98.91 NI
R1497 L. micdadei 100.00 2.3
R1501 L. micdadei 100.00 2.2
R1080 L. micdadei 99.82 2.2
R6091 L. micdadei 99.81 2.0
R3158 L. micdadei 99.77 2.2
R4134 L. micdadei 99.50 2.1
R5868 L. moravica 94.56/92.20 1.4
TABLE 1. Continued
Isolate no.
Presumptive
species
mip
percentage
MALDI-TOF
MS score
R3206 L. oakridgensis 100.00/NA Not Legionella
1.1/NI
R4650 L. rubrilucens 100.00 1.8
R5924 L. rubrilucens 100.00 2.0
R6074 L. rubrilucens 100.00 2.0
R3347 L. rubrilucens 99.82 2.0
NA, not available; NI, not identiﬁed.
Scores <2.0 are marked by bold, as are match percentages for mip sequencing
(lower limit = 98%).
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be L. dumoﬁi, with a score of 1.7. Legionella ‘91-004’ is an as
yet non-denominated species, found in Denmark and in
Japan (personal communication R. Ratcliff, Adelaide, Austra-
lia). The ﬁfth isolate with a score of <2.0 was correctly
identiﬁed by MALDI-TOF MS as L. anisa (R4587), with a
score of 1.8.
It was surprising that L. oakridgensis (R3206) did not match
with L. oakridgensis, as one isolate of this species was
included in the Bruker database, and Moliner et al. [8] found
even scores for ﬁve L. oakridgensis isolates with MALDI-
TOF MS, indicating low variation for this species. The strain
was recultured and re-examined with MALDI-TOF MS and
16S rRNA sequencing, but still no match was found by
MALDI-TOF MS; however, a 99% match with L. oakridgensis
was found with 16S rRNA sequencing.
Both mip sequencing and MALDI-TOF MS are reliable
methods for the identiﬁcation of Legionella species. Of the
two methods, mip sequencing is the most time-consuming
and costly; MALDI-TOF MS is fast and cheap. However, as
was found by Gaia et al. [14], the MALDI-TOF MS database
needs to be updated with more Legionella species, and pref-
erably several isolates of each species, to be suitable for use
as a routine method for Legionella identiﬁcation (especially in
water samples). With an optimized database, MALDI-
TOF MS might be able to replace sequencing, at least for
routine identiﬁcation, but, for ﬁnal species identiﬁcation,
DNA-based methods are still preferred. When MALDI-
TOF MS is used, it is important to rely only on results with
scores of ‡2.0, but with this cut-off the speciﬁcity seems to
be 100%. All isolates with a score of <2.0 must be conﬁrmed
by other methods, although values of 1.8–2.0 give very
strong indications.
Conclusions
The distribution of Legionella species was found to be differ-
ent in clinical samples and environmental samples. This might
be attributable to different pathogenicities of the different
Legionella species. This study conﬁrms that infections with
Legionella non-pneumophila species are rare, but that they
cause at least 4.5% of all cases of Legionnaires’ disease in
Denmark. PCR results suggest a higher proportion, but still
<10%. We recommend the use of PCR (or a similar method)
that can detect Legionella non-pneumophila species for the
routine diagnosis of Legionnaires’ disease. This is probably
the only method with a satisfactory sensitivity, but results
should be interpreted with caution; low levels of Legionella
non-pneumophila DNA can be found in samples from patients
who do not have Legionnaires’ disease.
MALDI-TOF MS was found to be a good and cheap alter-
native to mip sequencing; even without an optimal database
of Legionella spectra, most of the Legionella non-pneumophila
isolates were correctly identiﬁed.
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